Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DREAM: Decitabine in Myelodysplastic Syndrome
NCT02013102Phase 4Unknown
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Mar 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of decitabine in myelodysplastic syndrome (MDS), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Status: unknown.
02
Drugs
decitabine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT02013102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02013102.